WEBULL
News
EVGN
0.8422
+2.62%
0.0215
Weekly Report: what happened at EVGN last week (0216-0220)?
Weekly Report · 10h ago
Evogene Schedules Fourth Quarter and Full Year 2025 Financial Results Release
PR Newswire · 4d ago
Evogene collaborates with Queensland University in AI-driven cancer therapeutics
TipRanks · 6d ago
Evogene Partners With Research Group Of Dr. Mark Adams Over Discovery, Optimization Of Small Molecules To Treat Chemotherapy, Targeted Therapy-Resistant Non-small Cell Lung Cancer
Benzinga · 6d ago
Weekly Report: what happened at EVGN last week (0209-0213)?
Weekly Report · 02/16 10:11
Evogene Secures $3.4 Million Through Warrant Inducement Deal
TipRanks · 02/11 21:29
Evogene, Systasy And LMU University Hospital Collaborate To Accelerate Development Of Therapies For Hyper-Inflammatory Diseases Driven By Dysregulated Neutrophil Activity
Benzinga · 02/11 13:13
Evogene Announces a Warrant Inducement Transaction for Approximately $3.4 Million of Gross Proceeds
PR Newswire · 02/10 18:20
Evogene expands collaboration with Google Cloud for AI agents into ChemPass AI
TipRanks · 02/10 13:16
Evogene Announced An Expanded Phase Of Its Collaboration With Google Cloud That Would Focus On Developing And Integrating Advanced AI Agents Into Evogene's Chempass AI Platform, Its Engine For Small-molecule Discovery And Optimization, Using Google Cloud's Vertex AI Platform
Benzinga · 02/10 13:15
Evogene Appoints Prof. John Irwin and Prof. Dan Major to its Scientific Advisory Board
PR Newswire · 02/09 13:00
Weekly Report: what happened at EVGN last week (0202-0206)?
Weekly Report · 02/09 10:12
Evogene, Shanghai Lishan Biopharmaceuticals enter BMC128 licensing agreement
TipRanks · 02/05 11:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 02/04 21:05
Evogene’s Biomica Grants Lishan Biotech Global Rights to Microbiome Cancer Drug BMC128
TipRanks · 02/04 13:38
Evogene's Subsidiary Biomica Inks Exclusive Worldwide Licensing Agreement With Shanghai Lishan Biopharmaceuticals For BMC128, Deal Terms Were Not Disclosed
Benzinga · 02/04 13:17
Biomica and Lishan Biotech sign licensing agreement for BMC128
TipRanks · 02/04 13:05
Weekly Report: what happened at EVGN last week (0126-0130)?
Weekly Report · 02/02 10:12
Weekly Report: what happened at EVGN last week (0119-0123)?
Weekly Report · 01/26 10:12
Weekly Report: what happened at EVGN last week (0112-0116)?
Weekly Report · 01/19 10:17
More
Webull provides a variety of real-time EVGN stock news. You can receive the latest news about Evogene through multiple platforms. This information may help you make smarter investment decisions.
About EVGN
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.